The bHLH transcription factor CHF1/Hey2 regulates susceptibility to apoptosis and heart failure after pressure overload.
Cardiac hypertrophy is a common response to hemodynamic stress in the heart and can progress to heart failure. To investigate whether the transcription factor cardiovascular basic helix-loop-helix factor 1/hairy/enhancer of split related with YRPW motif 2 (CHF1/Hey2) influences the development of cardiac hypertrophy and progression to heart failure under conditions of pressure overload, we performed aortic constriction on 12-wk-old male wild-type (WT) and heterozygous (HET) mice globally underexpressing CHF1/Hey2. After aortic banding, WT and HET mice showed increased cardiac hypertrophy as measured by gravimetric analysis, as expected. CHF1/Hey2 HET mice, however, demonstrated a greater increase in the ventricular weight-to-body weight ratio compared with WT mice (P < 0.05). Echocardiographic measurements showed a significantly decreased ejection fraction compared with WT mice (P < 0.05). Histological examination of Masson trichrome-stained heart tissue demonstrated extensive fibrosis in HET mice compared with WT mice. TUNEL staining demonstrated increased apoptosis in HET hearts (P < 0.05). Exposure of cultured neonatal myocytes from WT and HET mice to H(2)O(2) and tunicamycin, known inducers of apoptosis that work through different mechanisms, demonstrated significantly increased apoptosis in HET cells compared with WT cells (P < 0.05). Expression of Bid, a downstream activator of the mitochondrial death pathway, was expressed in HET hearts at increased levels after aortic banding. Expression of GATA4, a transcriptional activator of cardiac hypertrophy, was also increased in HET hearts, as was phosphorylation of GATA4 at Ser(105). Our findings demonstrate that CHF1/Hey2 expression levels influence hypertrophy and the progression to heart failure in response to pressure overload through modulation of apoptosis and GATA4 activity.
Liu
Yonggang
Y
Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA.
Yu
Man
M
Wu
Ling
L
Chin
Michael T
MT
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000502:physiology*; D051792:Basic Helix-Loop-Helix Proteins / Q000502:physiology*; D002478:Cells, Cultured; D004195:Disease Models, Animal; D004198:Disease Susceptibility / Q000473:pathology / Q000503:physiopathology; D050991:GATA4 Transcription Factor / Q000378:metabolism; D006333:Heart Failure / Q000473:pathology / Q000503:physiopathology*; D006861:Hydrogen Peroxide / Q000494:pharmacology; D006973:Hypertension / Q000503:physiopathology*; D006984:Hypertrophy; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D032383:Myocytes, Cardiac / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D012097:Repressor Proteins / Q000502:physiology*; D014415:Tunicamycin / Q000494:pharmacology
D051792:Basic Helix-Loop-Helix Proteins; D050991:GATA4 Transcription Factor; D006861:Hydrogen Peroxide; D012097:Repressor Proteins; D014415:Tunicamycin; C484171:Gata4 protein, mouse; C485778:Hey2 protein, mouse
J Biol Chem. 2001 Aug 10;276(32):30245-53
11356841
J Mol Cell Cardiol. 2006 Feb;40(2):267-73
16242143
Curr Biol. 2002 Sep 17;12(18):1605-10
12372254
Mol Cell Biol. 2001 Nov;21(21):7460-9
11585926
Circ Res. 2007 Mar 30;100(6):850-5
17332425
J Mol Cell Cardiol. 2007 Feb;42(2):441-8
17187821
Circulation. 2007 Aug 14;116(7):700-5
17664372
J Clin Invest. 1997 Oct 1;100(7):1813-21
9312182
J Clin Invest. 2007 Jul;117(7):1782-93
17607355
Circ Res. 2004 Sep 3;95(5):540-7
15297376
J Clin Invest. 2008 Jan;118(1):124-32
18079970
Biochem J. 1989 Feb 15;258(1):73-8
2467662
Gene. 2006 Mar 15;369:7-19
16446060
Trends Mol Med. 2003 Apr;9(4):177-82
12727144
Mol Cell Biol. 2005 Oct;25(20):8960-70
16199874
Mol Cell Biol. 2001 Sep;21(17):6071-9
11486044
J Biol Chem. 2004 Dec 24;279(52):54937-43
15485867
JAMA. 1996 May 22-29;275(20):1557-62
8622246
Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):757-62
18178615
Curr Biol. 2002 Sep 17;12(18):1601-4
12372253
Circ Res. 2007 Mar 30;100(6):914-22
17332429
OMICS. 2009 Dec;13(6):501-11
20001863
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16197-202
12454287
Nat Rev Mol Cell Biol. 2006 Aug;7(8):589-600
16936699
Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2069-74
15345511
J Mol Cell Cardiol. 2008 Mar;44(3):453-9
18054039
Methods. 2001 Dec;25(4):402-8
11846609
J Biol Chem. 2000 Mar 3;275(9):6381-7
10692439
Circulation. 2002 Oct 15;106(16):2125-31
12379584
Am J Physiol Heart Circ Physiol. 2006 May;290(5):H1997-2006
16603706
Biochem Biophys Res Commun. 1999 Jul 5;260(2):459-65
10403790
J Clin Invest. 2003 Nov;112(9):1395-406
14597765
Physiol Genomics. 2004 Feb 13;16(3):349-60
14679301
Dev Biol. 1999 Dec 1;216(1):72-84
10588864